Antithrombotic Materials Dipyridamole Cardiovascular Dipyridamole

Name: Antithrombotic Materials Dipyridamole Cardiovascular Dipyridamole
Brand: Xi'an He Nirun Trading Co., Ltd.
SKU: 2298952115

Shaanxi, ChinaXi'an He Nirun Trading Co., Ltd.

US$30.00-100.00

1 kg

Sample price:US$30.00/kg.Request sample

Product profile

Powder

Yes

Customized

Certification

GMP, HSE, ISO 9001, USP, BP

Model NO.

HNR-Dipyridamole

Suitable for

Elderly, Children, Adult

State

Powder

Purity

>99%

Product Name

Dipyridamole

Name

Dipyridamole Power

CAS No.

58-32-2

Mf

C24h40n8o4

MW

504.62560

Application

Pharmaceutical

Density

1.352

Grade

Pharmaceutical Grade

Logp

0.11240

Pka

Pka 6.4 (Uncertain)

Appearance

Pale Yellow to Yellow Powder

Assay

99%

Specific

COA

Test Method

HPLC

Shelf Life

2 Years

Transport Package

Negotiable

Specification

99%

Trademark

HNR

Origin

Xian

Production Capacity

4000kg/Month

Key features

High purity stable supply, purity can reach 98% -99.5%

Support small batch sample trials, flexible MOQ

Long term stable supply, tiered price discounts

Complete compliance export qualifications, worry free customs clearance

Company profile

Xi'an He Nirun Trading Co., Ltd.Shaanxi, China

CertifiedBusiness Type: Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 1 yearNearest Port: Guangzhou, Beijing, HongkongAverage Response Time: ≤5.60h

AI-Powered supplier vetting

SummaryXi'an He Nirun Trading Co., Ltd. is identified as a limited trading company offering lactoferrin and fenbendazole, with PQQ also listed as a primary product in the audit record. It reports flexible customization, ODM services, recent new-product activity, and OEM services for well-known brands. However, the supplier has only one year of export experience, no overseas showroom, agents, branches, or offline trade-show participation, and its service coverage is recorded as zero countries. A BV audit is documented, but the audit evaluation result is recorded as 0 and the provided data does not identify a certification held. Financial-period records are present, but no financial performance details are provided. Production capability cannot be confirmed because the supplier is classified as a trading company and no manufacturing assets or capacity are stated.

Supplier typeThe supplier is explicitly identified as a limited company and a trading company, with no larger-company group affiliation. Its stated business scope includes sales and retail activities rather than documented manufacturing operations, indicating an intermediary or trading role.

After-Sales capabilityThe supplier has no overseas showroom, overseas agents or branches, offline trade-show participation, or recorded overseas service countries. It does provide stated quotation and payment-term options, but the service-capability assessment has no written procedures or followed records, so after-sales execution is not sufficiently demonstrated.

R&D capabilityThe supplier reports new products during the past year, provides ODM services, and offers multiple design-customization modes. However, it has no available SDK, so its broader technical-development capability is mixed rather than fully established.

Customization capabilityThe supplier explicitly offers customization from samples, customization from designs, full customization, minor customization, and flexible customization. It also reports ODM availability, providing direct evidence of broad customization support.

Product Q&A

Q:Do you have a MOQ?

We don't have the MOQ,you can tell me your purchase quantity

Q:What is the purity of your pharmaceutical intermediates?

The purity of conventional products is More than 99%, and special specifications can be customized to 99% or above. COA quality inspection reports are provided for each batch.

Q:Do you accept phased cooperation in small-scale, pilot, and mass production?

Support, small-scale sampling can be conducted first, and then pilot testing and large-scale production can be carried out after it is qualified.